Ming Hu Han

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. pmc Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders
    Ming Hu Han
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA
    Neuropharmacology 62:89-100. 2012
  2. doi request reprint Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway
    Jessica J Walsh
    1 Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA 2 Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 17:27-9. 2014
  3. doi request reprint G9a influences neuronal subtype specification in striatum
    Ian Maze
    Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York, USA
    Nat Neurosci 17:533-9. 2014
  4. pmc Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation
    Pamela J Kennedy
    Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 16:434-40. 2013
  5. pmc ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli
    Mary Kay Lobo
    Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, Departments of Psychiatry and of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York 10029, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, Department of Pharmacology and Toxicology and the Research Institute on Addictions, State University of New York at Buffalo, New York, New York 14214, and Institut National de la Sante et de la Recherche Medicale, U952, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7224, UPMC, Paris, 75005, France
    J Neurosci 33:18381-95. 2013
  6. pmc Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
    Dipesh Chaudhury
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
    Nature 493:532-6. 2013
  7. pmc HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
    Mitsumasa Kurita
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Nat Neurosci 15:1245-54. 2012

Collaborators

  • Scott J Russo
  • Ian Maze
  • Li Shen
  • Deveroux Ferguson
  • Anne Schaefer
  • Roger Cachope
  • Mitra Heshmati
  • Jian Feng
  • Javier Gonzalez-Maeso
  • Gustavo Turecki
  • Dipesh Chaudhury
  • Eric J Nestler
  • Jessica J Walsh
  • Ja Wook Koo
  • Allyson K Friedman
  • Mary Kay Lobo
  • Ezekiell Mouzon
  • Pamela J Kennedy
  • Jeffrey M Friedman
  • Daniel J Christoffel
  • Michelle S Mazei-Robison
  • Stacy M Ku
  • Barbara Juarez
  • LISA POMERANZ
  • Diane M Damez-Werno
  • Sam A Golden
  • Rachael L Neve
  • David M Dietz
  • Mitsumasa Kurita
  • Veronica L Burnham
  • Haosheng Sun
  • Elizabeth A Heller
  • Karl Deisseroth
  • Eric N Olson
  • Yasmin L Hurd
  • Alexandria Nugent
  • Alexander R Nectow
  • Rhonda Bassel-Duby
  • Stephen J Haggarty
  • Samir Zaman
  • David W Self
  • Mats Ekstrand
  • Hsing Chen Tsai
  • Rosemary C Bagot
  • A J Robison
  • Ramesh Chandra
  • Eric Finkel
  • Jacqui Rabkin
  • Ana Badimon
  • Ana Domingos
  • Vincent Vialou
  • Efrain Riberio
  • Joseph F Cheer
  • Jennifer A DiNieri
  • Aintzane García-Bea
  • Ane M Gabilondo
  • Joseph D Buxbaum
  • Giuseppe Mocci
  • Amelia L Gallitano
  • J Javier Meana
  • Terrell Holloway
  • James Hanks
  • Alexey Kozlenkov
  • Adrienne Umali
  • Jose L Moreno
  • Luis F Callado
  • Nagahide Takahashi

Detail Information

Publications7

  1. pmc Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders
    Ming Hu Han
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, NY, USA
    Neuropharmacology 62:89-100. 2012
    ..This article is part of a Special Issue entitled 'Anxiety and Depression'...
  2. doi request reprint Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway
    Jessica J Walsh
    1 Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York, USA 2 Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 17:27-9. 2014
    ..This stress gating of BDNF signaling is mediated by corticotrophin-releasing factor (CRF) acting in the NAc. These results unravel a stress context-detecting function of the brain's mesolimbic circuit. ..
  3. doi request reprint G9a influences neuronal subtype specification in striatum
    Ian Maze
    Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, New York, USA
    Nat Neurosci 17:533-9. 2014
    ....
  4. pmc Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation
    Pamela J Kennedy
    Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
    Nat Neurosci 16:434-40. 2013
    ..Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction...
  5. pmc ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli
    Mary Kay Lobo
    Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, Departments of Psychiatry and of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, New York 10029, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, Department of Pharmacology and Toxicology and the Research Institute on Addictions, State University of New York at Buffalo, New York, New York 14214, and Institut National de la Sante et de la Recherche Medicale, U952, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7224, UPMC, Paris, 75005, France
    J Neurosci 33:18381-95. 2013
    ..Together, these findings establish selective patterns of ΔFosB induction in striatal MSN subtypes in response to chronic stimuli and provide novel insight into the circuit-level mechanisms of ΔFosB induction in striatum. ..
  6. pmc Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons
    Dipesh Chaudhury
    Department of Pharmacology and Systems Therapeutics, Friedman Brain Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
    Nature 493:532-6. 2013
    ..Overall, these studies reveal novel firing-pattern- and neural-circuit-specific mechanisms of depression...
  7. pmc HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
    Mitsumasa Kurita
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Nat Neurosci 15:1245-54. 2012
    ..These observations support the view of HDAC2 as a promising new target for schizophrenia treatment...